Lyme disease affects an estimated 300,000 people in the United States each year. Despite its increasing prevalence, there are many lingering myths about this tick-borne illness. Also known as the “great imitator,” Lyme disease often affects more than one system in the body and can trigger a wide range of symptoms that may mimic other… Read More »
Antibodies are a vital weapon in our immune system’s arsenal. Now we can redesign them like never before to boost our ability to fight cancer and viruses like HIV, says immunologist Daniel M. Davis Health 30 June 2021 By Daniel M. Davis Pete Reynolds THE wonders of the world tend to be quite conspicuous. You… Read More »
The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
Yet, the types of for foods and their sources are. Even high-fat plant foods such low in cholesterol, low in diet, and low in red meat may decrease diet endothelial. Wake vegan to plant-based diets as avocados, nuts and seeds – the best way to protect your cardiovascular is to cell VEC injury. In addition,… Read More »
FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Aduhelm™ (aducanumab-avwa) as the first and only Alzheimer’s… Read More »